Pacific Biosciences Of California
(NASDAQ) PACB
Pacific Biosciences Of California Financials at a Glance
Market Cap
$477.16M
Revenue (TTM)
$160.00M
Net Income (TTM)
$546.38M
EPS (TTM)
$-1.83
P/E Ratio
-0.86
Dividend
$0.00
Beta (Volatility)
2.39 (High)
Dividend
$0.00
Beta (Volatility)
2.39 (High)
Price
$1.47
Volume
5,892,336.675
Open
$1.56
Price
$1.47
Volume
5,892,336.675
Open
$1.56
Previous Close
$1.47
Daily Range
$1.42 - $1.56
52-Week Range
$0.85 - $2.73
Dividend
$0.00
Beta (Volatility)
2.39 (High)
Price
$1.47
Volume
5,892,336.675
Open
$1.56
Previous Close
$1.47
Daily Range
$1.42 - $1.56
52-Week Range
$0.85 - $2.73
PACB News
PACB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pacific Biosciences Of California
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
485
CEO
Christian O. Henry, MBA
Website
www.pacb.comHeadquarters
Menlo Park, CA 94025, US
PACB Financials
Key Financial Metrics (TTM)
Gross Margin
28%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-213%
Return on Capital
-76%
Return on Assets
-70%
Earnings Yield
-1.16%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$477.16M
Shares Outstanding
302.00M
Volume
5.89M
Avg. Volume
6.35M
Financials (TTM)
Gross Profit
$50.67M
Operating Income
$557.56M
EBITDA
$34.20M
Operating Cash Flow
$111.21M
Capital Expenditure
$2.71M
Free Cash Flow
$113.92M
Cash & ST Invst.
$279.51M
Total Debt
$759.46M
Pacific Biosciences Of California Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$44.65M
+13.8%
Gross Profit
$16.75M
+66.5%
Gross Margin
37.52%
N/A
Market Cap
$477.16M
N/A
Market Cap/Employee
$829.84K
N/A
Employees
575
N/A
Net Income
$40.37M
-1802.7%
EBITDA
$38.43M
-334.4%
Quarterly Fundamentals
Net Cash
$479.96M
-69.9%
Accounts Receivable
$35.45M
+28.8%
Inventory
$49.28M
-16.1%
Long Term Debt
$759.46M
+14.7%
Short Term Debt
$448.00K
-95.5%
Return on Assets
-69.68%
N/A
Return on Invested Capital
-75.90%
N/A
Free Cash Flow
$24.93M
+22.7%
Operating Cash Flow
$19.07M
+37.8%